The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists

Authors

  • Nina H. Bjarnason Department of Clinical Pharmacology, Gentofte Hospital, Denmark; Department of Clinical Pharmacology, Rigshospitalet, Denmark
  • Michael Christiansen Statens Serum Institut, Denmark
  • Lena Specht Department of Oncology, Rigshospitalet, Denmark

DOI:

https://doi.org/10.1080/02841860701381242

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

2008-01-01

How to Cite

Bjarnason, N. H. ., Christiansen, M. ., & Specht, L. . (2008). The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists. Acta Oncologica, 47(1), 150–151. https://doi.org/10.1080/02841860701381242

Issue

Vol. 47 No. 1 (2008): Acta Oncologica

Section

Articles